Previous studies have shown that cochlear kanamycin injections which produce deafness, resulted in a significant reduction of VGLUT-1 in the regions of the ventral and dorsal cochlear nucleus receiving auditory nerve inputs as well as an increase of VGLUT-2 in regions receiving non auditory inputs [34]. Here, SLC17A7 is linked to deafness.